Wed, September 2, 2020
Tue, September 1, 2020
Mon, August 31, 2020

Leland Gershell Downgraded (ACST) to Hold on, Sep 1st, 2020

Leland Gershell of Oppenheimer, Downgraded "Acasti Pharma Inc." (ACST) to Hold on, Sep 1st, 2020.

Leland has made no other calls on ACST in the last 4 months.



There are 2 other peers that have a rating on ACST. Out of the 2 peers that are also analyzing ACST, 0 agree with Leland's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Leland


  • Mayank Mamtani of "B. Riley Securities" Upgraded from Hold to Strong Buy and Held Target at $96 on, Monday, July 6th, 2020
  • Nathan Weinstein of "Aegis Capital" Maintained at Strong Buy with Decreased Target to $103 on, Wednesday, May 6th, 2020